Home β€Ί Stock analysis β€Ί CTSO

Cytosorbents (CTSO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

CTSO dips 1.0% to $3.06, a 52-week low, 4 down days in a row. Closed at $3.06, -0.97% vs the prior close of $3.09. Day range $2.84–$3.09, opened at $2.95.

Last close$3.06-0.97%
Day range2.84–3.09
Open2.95
Volume10.80K
52-week range2.84–18.80
Avg volume (20d)11.55K

CTSO daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” CTSO dips 1.0% to $3.06, a 52-week low, 4 down days in a row
Oct 14, 2026 β€” CTSO slides 10.7% to $3.09, a 52-week low, 3 down days in a row
Oct 13, 2026 β€” CTSO slides 3.6% to $3.46, a 52-week low
Oct 12, 2026 β€” CTSO slides 5.3% to $3.59, a 52-week low
Oct 9, 2026 β€” CTSO rises 1.6% to $3.79
Oct 8, 2026 β€” CTSO slides 3.6% to $3.73, a 52-week low, 5 down days in a row
Oct 7, 2026 β€” CTSO dips 2.3% to $3.87, a 52-week low, 4 down days in a row
Oct 6, 2026 β€” CTSO ends flat (-0.1%) to $3.96, 3 down days in a row
Oct 5, 2026 β€” CTSO dips 2.1% to $3.96
Oct 2, 2026 β€” CTSO slides 3.2% to $4.05

CTSO latest news & SEC filings

Every SEC filing by or about CTSO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 23, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-109814

Sep 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-108326

Sep 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-108247

Sep 16, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-108246

Sep 9, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001104659-26-106308

Sep 8, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-105901

Aug 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-097092

Aug 7, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-092691

Aug 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001104659-26-092039

Aug 6, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001104659-26-092006

Jul 6, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-080741

Jun 25, 2026 Β· Form ARS β€” Annual report to shareholders

Annual report to shareholders

Source: SEC EDGAR filing 0001104659-26-077808

Jun 25, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001104659-26-077803

Jun 25, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001104659-26-077798

Jun 25, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-077584

Things to know before you trade CTSO

CTSO market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20262.953.092.843.0610.80K
Oct 14, 20263.393.462.963.0916.50K
Oct 13, 20263.653.653.423.4610.20K
Oct 12, 20263.653.823.513.598.30K
Oct 9, 20263.673.803.593.796.20K
Oct 8, 20263.813.813.673.7310.80K
Oct 7, 20264.004.063.843.876.40K
Oct 6, 20264.074.293.893.9624.80K
Oct 5, 20263.854.053.663.968.40K
Oct 2, 20264.174.293.834.0512.50K
Oct 1, 20264.384.503.934.188.30K
Sep 30, 20264.134.153.773.9013.70K
Sep 29, 20264.084.484.004.009.80K
Sep 28, 20264.284.573.974.0214.30K
Sep 25, 20264.444.834.334.386.50K
Sep 24, 20265.205.203.944.3024.90K
Sep 23, 20265.255.364.894.916.10K
Sep 22, 20265.535.595.315.326.40K
Sep 21, 20265.795.795.165.5114.30K
Sep 18, 20265.886.005.505.7511.80K

About Cytosorbents

Cytosorbents (CTSO) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in PRINCETON, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1175151.

CTSO board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Phillip P. ChanChief Executive OfficerSep 16, 2026
Alan D. SobelDirectorSep 16, 2026

Executive officers

NameTitleLatest filing
Vincent CapponiPresident and COOSep 16, 2026
Phillip P. ChanChief Executive OfficerSep 16, 2026
Peter J MarianiChief Financial OfficerJun 16, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 15, 2026Phillip P. ChanBuy3,774$6.00
Sep 15, 2026Alan D. SobelBuy100$6.01
Sep 15, 2026Alan D. SobelBuy1,900$6.12
Sep 15, 2026Alan D. SobelBuy500$6.05
Sep 14, 2026Vincent CapponiBuy273$5.90
Sep 14, 2026Vincent CapponiBuy1,800$6.07
Sep 4, 2026Phillip P. ChanBuy200,000$0.35
Jun 15, 2026Peter J MarianiBuy100,000$0.44
Jun 15, 2026Phillip P. ChanBuy10,333$0.43
Jun 12, 2026Phillip P. ChanBuy251,136$0.40

CTSO financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-8.20M-0.13$-12.38M
Dec 31, 2024β€”$-20.72M-0.38$-14.43M
Dec 31, 2023β€”$-29.25M-0.65$-21.66M
Dec 31, 2022β€”$-32.81M-0.75$-28.23M
Dec 31, 2021β€”$-24.56M-0.57$-14.01M

Latest balance sheet: total assets $37.96M, total liabilities $38.71M, cash $4.41M (as of Jun 30, 2026).

CTSO earnings / results-day log

DateFilingClose that day
Aug 6, 20268-K Item 2.02 (results)$7.98
May 13, 20268-K Item 2.02 (results)$11.42
Mar 25, 20268-K Item 2.02 (results)$13.42
Nov 13, 20258-K Item 2.02 (results)$13.32
May 14, 20258-K Item 2.02 (results)$16.16
Mar 31, 20258-K Item 2.02 (results)$20.00
Mar 21, 20258-K Item 2.02 (results)$19.68
Mar 4, 20258-K Item 2.02 (results)$20.00
Jan 13, 20258-K Item 2.02 (results)$21.00
Jan 3, 20258-K Item 2.02 (results)$18.74
Nov 7, 20248-K Item 2.02 (results)$18.06
Oct 1, 20248-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on CTSO

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.